TransMedics Group (TMDX) PT Raised to $44 at Oppenheimer
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Price: $88.35 +1.53%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Suraj Kalia raised the price target on TransMedics Group (NASDAQ: TMDX) to $44.00 (from $40.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Riskified Ltd. (RSKD) PT Raised to $7.50 at DA Davidson on Improving New Business Trends
- MongoDB (MDB) PT Raised at RBC Capital; 'Shares represent an attractive buying opportunity'
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
